# Fenofibrate Treatment in SCI

> **NCT02455336** · PHASE2,PHASE3 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 23 (actual)

## Conditions studied

- Spinal Cord Injury
- Dyslipidemia

## Interventions

- **DRUG:** Fenofibrate
- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT02455336
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-18
- **Primary completion:** 2018-08-01
- **Final completion:** 2018-08-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2019-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02455336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02455336, "Fenofibrate Treatment in SCI". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02455336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*